TEVA NYSE
Teva Pharmaceutical Industries Limited
1W: +0.9%
1M: +5.4%
3M: +12.0%
YTD: +27.7%
1Y: +97.1%
3Y: +294.9%
5Y: +341.7%
$39.53
+0.22 (+0.56%)
Weekly Expected Move ±4.2%
$36
$38
$40
$41
$43
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$1.6B
+32.2% ▲
5Y CAGR: +6.3%
Capital Expenditures
$501M
-0.6% ▼
5Y CAGR: -2.8%
Free Cash Flow
$1.1B
+53.3% ▲
5Y CAGR: +12.5%
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$256M
+250.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $456M | -$2.4B | -$615M | -$1.6B | $1.4B |
| Depreciation & Amort. | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B |
| Stock-Based Comp. | $119M | $124M | $121M | $0 | $157M |
| Change in Working Capital | -$1.7B | $1.3B | -$72M | -$437M | -$1.4B |
| Other Non-Cash Items | $714M | $2.4B | $1.1B | $4.2B | $1.1B |
| Operating Cash Flow | $798M | $1.6B | $1.4B | $2.6B | $1.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$562M | -$548M | -$526M | -$500M | -$501M |
| Acquisitions (Net) | $2.0B | $61M | $68M | -$79M | $34M |
| Investment Purchases | -$47M | -$1M | -$46M | $0 | -$57M |
| Investment Sales | $172M | $4M | $0 | $40M | $42M |
| Other Investing | $1M | $1.1B | $1.5B | -$26M | $1.2B |
| Investing Cash Flow | $1.5B | $656M | $968M | -$566M | $737M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2.2B | -$1.4B | -$1.7B | -$1.6B | -$1.8B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$6M | -$118M | -$212M | -$86M | -$337M |
| Financing Cash Flow | -$2.2B | -$1.5B | -$1.9B | -$1.7B | -$2.2B |
| Net Change in Cash | $21M | $636M | $393M | $74M | $256M |
| Cash End of Period | $2.2B | $2.8B | $3.2B | $3.3B | $3.6B |
| Free Cash Flow | $236M | $1.0B | $842M | $2.0B | $1.1B |